Advanced search
Publication Cover
Cancer Biology & Therapy Volume 15, 2014 - Issue 10
Submit an article Journal homepage
914
Views
22
CrossRef citations to date
0
Altmetric
Research Paper

Strategic targeting of the PI3K–NFκB axis in cisplatin-resistant NSCLC

Susan Heavey Thoracic Oncology Research Group; Institute of Molecular Medicine; Trinity Centre for Health Sciences; St. James’s Hospital; Dublin, IrelandCorrespondence[email protected]
,
Peter Godwin Thoracic Oncology Research Group; Institute of Molecular Medicine; Trinity Centre for Health Sciences; St. James’s Hospital; Dublin, Ireland
,
Anne-Marie Baird Cancer & Ageing Research Program; Queensland University of Technology; Brisbane, QLD Australia
,
Martin P Barr Thoracic Oncology Research Group; Institute of Molecular Medicine; Trinity Centre for Health Sciences; St. James’s Hospital; Dublin, Ireland
,
Kazuo Umezawa Department of Molecular Target Medicine; Aichi Medical University; Nagakute, Japan
,
Sinéad Cuffe Thoracic Oncology Research Group; Institute of Molecular Medicine; Trinity Centre for Health Sciences; St. James’s Hospital; Dublin, Ireland
,
Stephen P Finn Thoracic Oncology Research Group; Institute of Molecular Medicine; Trinity Centre for Health Sciences; St. James’s Hospital; Dublin, Ireland
,
Kenneth J O’Byrne Cancer & Ageing Research Program; Queensland University of Technology; Brisbane, QLD Australia
&
Kathy Gately Thoracic Oncology Research Group; Institute of Molecular Medicine; Trinity Centre for Health Sciences; St. James’s Hospital; Dublin, Ireland
 show all
Pages 1367-1377 | Received 16 May 2014, Accepted 06 Jul 2014, Published online: 15 Jul 2014

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yanshi Xue, Lin Yang, Junzun Li, Yilin Yan, Qinghui Jiang, Lan Shen, Shuai Yang, Bing Shen, Ruimin Huang, Jun Yan & Hongqian Guo. (2018) Combination chemotherapy with Zyflamend reduced the acquired resistance of bladder cancer cells to cisplatin through inhibiting NFκB signaling pathway. OncoTargets and Therapy 11, pages 4413-4429.
Read now

Articles from other publishers (21)

Rumei Luan, Dongyan Ding, Qianfei Xue, Han Li, Yujuan Wang & Junling Yang. (2022) Protective role of zinc in the pathogenesis of respiratory diseases. European Journal of Clinical Nutrition 77:4, pages 427-435.
Crossref
Kai-ling Coleman, Michael Chiaramonti, Ben Haddad, Robert Ranzenberger, Heather Henning, Hind Al Khashali, Ravel Ray, Ban Darweesh, Jeffrey Guthrie, Deborah Heyl & Hedeel Guy Evans. (2023) Phosphorylation of IGFBP-3 by Casein Kinase 2 Blocks Its Interaction with Hyaluronan, Enabling HA-CD44 Signaling Leading to Increased NSCLC Cell Survival and Cisplatin Resistance. Cells 12:3, pages 405.
Crossref
Ravel Ray, Hind Al Khashali, Ben Haddad, Jadziah Wareham, Kai-Ling Coleman, Danyah Alomari, Robert Ranzenberger, Jeffrey Guthrie, Deborah Heyl & Hedeel Guy Evans. (2022) Regulation of Cisplatin Resistance in Lung Cancer Cells by Nicotine, BDNF, and a β-Adrenergic Receptor Blocker. International Journal of Molecular Sciences 23:21, pages 12829.
Crossref
Preetish Kadur Lakshminarasimha Murthy, Rui Xi, Diana Arguijo, Jeffrey I. Everitt, Dewran D. Kocak, Yoshihiko Kobayashi, Aline Bozec, Silvestre Vicent, Shengli Ding, Gregory E. Crawford, David Hsu, Purushothama Rao Tata, Timothy Reddy & Xiling Shen. (2022) Epigenetic basis of oncogenic-Kras-mediated epithelial-cellular proliferation and plasticity. Developmental Cell 57:3, pages 310-328.e9.
Crossref
Xiaolong Miao, Chen Liu, Yuancong Jiang, Yao Wang, Deqiang Kong, Zelai Wu, Xinyi Wang, Rui Tian, Xing Yu, Xuhang Zhu & Weihua Gong. (2021) BET protein inhibition evidently enhances sensitivity to PI3K/mTOR dual inhibition in intrahepatic cholangiocarcinoma. Cell Death & Disease 12:11.
Crossref
Biswadeep Das, Chayna Sarkar, Vikram Singh Rawat, Deepjyoti Kalita, Sangeeta Deka & Akash Agnihotri. (2021) Promise of the NLRP3 Inflammasome Inhibitors in In Vivo Disease Models. Molecules 26:16, pages 4996.
Crossref
Tingting Cai, Jieqi Zhou, Yuanyuan Zeng, Wenwen Du, Yang Zhang, Ting Liu, Yulong Fu, Jian-an Huang, Qian Qian, Jianjie Zhu, Chunhua Ling & Zeyi Liu. (2020) EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Foteinos-Ioannis D. Dimitrakopoulos, Anastasia E. Kottorou, Melpomeni Kalofonou & Haralabos P. Kalofonos. (2020) The Fire Within: NF-κB Involvement in Non–Small Cell Lung Cancer. Cancer Research 80:19, pages 4025-4036.
Crossref
Sabina Luszczak, Benjamin S. Simpson, Urszula Stopka-Farooqui, Vignesh Krishna Sathyadevan, Lina M. Carmona Echeverria, Christopher Kumar, Helena Costa, Aiman Haider, Alex Freeman, Charles Jameson, Marzena Ratynska, Imen Ben-Salha, Ashwin Sridhar, Greg Shaw, John D. Kelly, Hayley Pye, Kathy A. Gately, Hayley C. Whitaker & Susan Heavey. (2020) Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer. Scientific Reports 10:1.
Crossref
Surya Kant Tripathi, Kannan R. R. Rengasamy & Bijesh Kumar Biswal. (2020) Plumbagin engenders apoptosis in lung cancer cells via caspase-9 activation and targeting mitochondrial-mediated ROS induction. Archives of Pharmacal Research 43:2, pages 242-256.
Crossref
Sabina Luszczak, Christopher Kumar, Vignesh Krishna Sathyadevan, Benjamin S. Simpson, Kathy A. Gately, Hayley C. Whitaker & Susan Heavey. (2020) PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer. Signal Transduction and Targeted Therapy 5:1.
Crossref
Manling Hu, Jing Yang, Linlin Qu, Xuqian Deng, Zhiguang Duan, Rongzhan Fu, Lihua Liang & Daidi Fan. (2020) Ginsenoside Rk1 induces apoptosis and downregulates the expression of PD-L1 by targeting the NF-κB pathway in lung adenocarcinoma. Food & Function 11:1, pages 456-471.
Crossref
Lin Shi, Zhaozhong Xu, Qiong Yang, Yuanyuan Huang, Yuxin Gong, Fang Wang & Bin Ke. (2019) IL‐7–Mediated IL‐7R‐JAK3/STAT5 signalling pathway contributes to chemotherapeutic sensitivity in non–small‐cell lung cancer. Cell Proliferation 52:6.
Crossref
Mao-Chi Weng, Ming-Hsin Li, Jing Gung Chung, Yu-Chang Liu, Jeng-Yuan Wu, Fei-Ting Hsu & Hsin-Ell Wang. (2019) Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo. Biomedicine & Pharmacotherapy 116, pages 109032.
Crossref
Arielis Rodríguez-Ulloa, Yassel Ramos, Aniel Sánchez-Puente, Yasser Perera, Alexis Musacchio-Lasa, Jorge Fernández-de-Cossio, Gabriel Padrón, Luis J.G. López, Vladimir Besada & Silvio E. Perea. (2019) The Combination of the CIGB-300 Anticancer Peptide and Cisplatin Modulates Proteins Related to Cell Survival, DNA Repair and Metastasis in a Lung Cancer Cell Line Model. Current Proteomics 16:4, pages 338-349.
Crossref
Liping Chen, Bixia Weng, Huimin Li, Haonan Wang, Qian Li, Xiaoyan Wei, Hui Deng, Sicen Wang, Chengxi Jiang, Renyu Lin & Jianzhang Wu. (2018) A thiopyran derivative with low murine toxicity with therapeutic potential on lung cancer acting through a NF-κB mediated apoptosis-to-pyroptosis switch. Apoptosis 24:1-2, pages 74-82.
Crossref
Liping Chen, Qian Li, Bixia Weng, Jiabing Wang, Yangyang Zhou, Dezhi Cheng, Thanchanok Sirirak, Peihong Qiu & Jianzhang Wu. (2018) Design, synthesis, anti-lung cancer activity, and chemosensitization of tumor-selective MCACs based on ROS-mediated JNK pathway activation and NF-κB pathway inhibition. European Journal of Medicinal Chemistry 151, pages 508-519.
Crossref
Susan Heavey, Paul Dowling, Gillian Moore, Martin P. Barr, Niamh Kelly, Stephen G. Maher, Sinead Cuffe, Stephen P. Finn, Kenneth J. O’Byrne & Kathy Gately. (2018) Development and characterisation of a panel of phosphatidylinositide 3-kinase – mammalian target of rapamycin inhibitor resistant lung cancer cell lines. Scientific Reports 8:1.
Crossref
Susan Heavey, Sinead Cuffe, Stephen Finn, Vincent Young, Ronan Ryan, Siobhan Nicholson, Niamh Leonard, Niall McVeigh, Martin Barr, Kenneth O’Byrne & Kathy Gately. (2016) In pursuit of synergy: An investigation of the PI3K/mTOR/MEK co-targeted inhibition strategy in NSCLC. Oncotarget 7:48, pages 79526-79543.
Crossref
Shanzhou Duan, Ying Tsai, Peter Keng, Yongbing Chen, Soo Ok Lee & Yuhchyau Chen. (2015) IL-6 signaling contributes to cisplatin resistance in non-small cell lung cancer via the up-regulation of anti-apoptotic and dna repair associated molecules. Oncotarget 6:29, pages 27651-27660.
Crossref
Sylvie Hermouet, Edith Bigot-Corbel & Betty Gardie. (2015) Pathogenesis of Myeloproliferative Neoplasms: Role and Mechanisms of Chronic Inflammation. Mediators of Inflammation 2015, pages 1-16.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.